Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.
Press releases published on April 9, 2025
UNITED WAY OF HUNTERDON COUNTY ANNOUNCES LAUNCH OF ‘UNITED IN PLAY’
EIN Presswire
·
April 9, 2025
A PROGRAM ADDRESSING YOUTH MENTAL HEALTH CRISIS THROUGH SPORTS FLEMINGTON, NJ, UNITED STATES, April 9, 2025 /EINPresswire.com/ -- Recognizing the urgent youth mental health crisis and the well-documented benefits of physical activity on mental well- …
Cosmetic Dentist Dr. Radwa Saad Named KOL & National Speaker for SureSmile by Dentsply Sirona, Representing New Jersey
EIN Presswire
·
April 9, 2025
PRINCETON, NJ, UNITED STATES, April 9, 2025 /EINPresswire.com/ -- In a major recognition of clinical excellence and innovation, Cosmetic Dentist Dr. Radwa Saad, founder of Dent Blanche Dental, has been selected as a Key Opinion Leader (KOL) and national …
The Feline Veterinary Medical Association Advocates for Proper Socialization of Kittens
EIN Presswire
·
April 9, 2025
The FelineVMA highlights the importance of proper socialization for kittens in the "FelineVMA Position Statement on the Socialization of Feral Kittens" BRIDGEWATER TOWNSHIP, NJ, UNITED STATES, April 9, 2025 /EINPresswire.com/ -- Supporting Healthy Cat- …
NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
April 9, 2025
TORONTO and HAIFA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to provide a business update and reported financial results for the fourth quarter and …
Codexis Announces Byron Dorgan to Retire from Board of Directors
GlobeNewswire
·
April 9, 2025
REDWOOD CITY, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that Byron Dorgan will retire from the Company’s Board …
COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update
GlobeNewswire
·
April 9, 2025
Fully repositioned as a pure-play natural-based product company following strategic review and pipeline prioritization Ongoing streamlined efficiencies and cost cutting measures taken to refine operations and development pathway forward; Company ended the …
Procaps Group assegura um investimento de capital de 130 milhões de dólares e conclui uma reestruturação abrangente de dívidas, enquanto novos investidores assumem a liderança estratégica
GlobeNewswire
·
April 9, 2025
Novos investidores assumem a liderança estratégica enquanto a sede é transferida para Bogotá, marcando o início de um novo capítulo de crescimento, execução e transformação sob uma governança aprimorada A empresa acelera sua reviravolta com mudanças na …
Procaps Group asegura una inversión de capital de 130 millones de dólares y completa una reestructuración integral de deuda, mientras nuevos inversores asumen el liderazgo estratégico
GlobeNewswire
·
April 9, 2025
Nuevos inversores asumen el liderazgo estratégico mientras la sede se traslada a Bogotá, marcando el comienzo de un nuevo capítulo de crecimiento, ejecución y transformación bajo una gobernanza mejorada La empresa acelera su recuperación con cambios en el …
Procaps Group Secures $130 Million in Equity Investment and Completes Comprehensive Debt Restructuring, as New Investors Take Over Strategic Leadership
GlobeNewswire
·
April 9, 2025
New Investors Take Over the Strategic Leadership as Headquarters Move to Bogotá, Marking the Start of a New Chapter of Growth, Execution, and Transformation under Enhanced Governance Company Accelerates Turnaround with Leadership Changes, Regional …
Venus Concept Announces $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
·
April 9, 2025
TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into definitive agreements for the purchase and sale of 328, …
Tempest Announces Plan to Explore Strategic Alternatives to Advance Promising Pipeline of Clinical Oncology Assets and Maximize Stockholder Value
GlobeNewswire
·
April 9, 2025
Amezalpat (TPST-1120) is Phase 3-ready: completed FDA and EMA interactions for first-line pivotal study in hepatocellular carcinoma (HCC); global investigator support in place Awarded both Orphan Drug …
Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients’ Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home
GlobeNewswire
·
April 9, 2025
GARDEN CITY, N.Y., April 09, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives …
Iridex to Host Strategic Vision Call on April 16, 2025
GlobeNewswire
·
April 9, 2025
MOUNTAIN VIEW, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 9, 2025
BRISBANE, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on April 3, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 211,250 shares of …
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025
GlobeNewswire
·
April 9, 2025
VALENCIA, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering a portfolio of transformative solutions, today announced 16 abstracts to be presented at the …
Corvus Pharmaceuticals Appoints Richard A. van den Broek to Board of Directors
GlobeNewswire
·
April 9, 2025
SOUTH SAN FRANCISCO, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, announced today that Richard van den Broek, managing partner at HSMR Advisors, has been appointed to …
Kayal Foot & Ankle Center: Pioneering Excellence in Podiatric Care
EIN Presswire
·
April 9, 2025
NJ Top Docs has reviewed and approved Dr. Theresa Ronna, Dr. Christopher E. Hubbard, and Dr. Raymond Maimone of Kayal Foot …
Tevogen Announces Tevogen Generics, a New Effort in Support of President Trump’s Initiative to Encourage Pharmaceutical Manufacturing in United States
GlobeNewswire
·
April 9, 2025
WARREN, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announces its newest effort: Tevogen Generics. This effort is in response to the growing national focus on pharmaceutical …
Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L
GlobeNewswire
·
April 9, 2025
CHICAGO, April 09, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…
Sodium Channel Blockers Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
GlobeNewswire
·
April 9, 2025
New York, USA, April 09, 2025 (GLOBE NEWSWIRE) -- Sodium Channel Blockers Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight The sodium channel blocker market is expanding due to the …